| Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine S Gupta, K Chaudhary, R Kumar, A Gautam, JS Nanda, SK Dhanda, ... Scientific reports 6 (1), 23857, 2016 | 81 | 2016 |
| Topical delivery of protein and peptide using novel cell penetrating peptide IMT-P8 A Gautam, JS Nanda, JS Samuel, M Kumari, P Priyanka, G Bedi, SK Nath, ... Scientific reports 6 (1), 26278, 2016 | 78 | 2016 |
| dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes J Singh Nanda, R Kumar, GPS Raghava Scientific reports 6 (1), 19340, 2016 | 64 | 2016 |
| Role of Swi6/HP1 self-association-mediated recruitment of Clr4/Suv39 in establishment and maintenance of heterochromatin in fission yeast S Haldar, A Saini, JS Nanda, S Saini, J Singh Journal of Biological Chemistry 286 (11), 9308-9320, 2011 | 59 | 2011 |
| Ablation of RNA interference and retrotransposons accompany acquisition and evolution of transposases to heterochromatin protein CENPB U Upadhyay, S Srivastava, I Khatri, JS Nanda, S Subramanian, A Arora, ... Molecular biology of the cell 28 (8), 1132-1146, 2017 | 25 | 2017 |
| Identification of Genes Required for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cells In Vitro SE Kohrt, WN Awadallah, RA Phillips III, TC Case, R Jin, JS Nanda, X Yu, ... Molecular cancer therapeutics 20 (2), 398-409, 2021 | 20 | 2021 |
| Increased nuclear factor I/B expression in prostate cancer correlates with AR expression JS Nanda, WN Awadallah, SE Kohrt, P Popovics, JMM Cates, ... The Prostate 80 (13), 1058-1070, 2020 | 10 | 2020 |
| Role of Cdc23/Mcm10 in generating the ribonucleotide imprint at the mat1 locus in fission yeast B Singh, KK Bisht, U Upadhyay, AC Kushwaha, JS Nanda, S Srivastava, ... Nucleic acids research 47 (7), 3422-3433, 2019 | 9 | 2019 |
| Phenotypic plasticity-alternate transcriptional programs driving treatment resistant prostate cancer JS Nanda, P Koganti, G Perri, L Ellis Critical Reviews™ in Oncogenesis 27 (1), 2022 | 5 | 2022 |
| An RNAi-independent role of AP1-like stress response factor Pap1 in centromere and mating-type silencing in Schizosaccaromyces pombe A Kumar, JS Nanda, S Saini, J Singh Journal of Biosciences 46, 1-14, 2021 | 2 | 2021 |
| Nuclear factor I/B increases in prostate cancer to support androgen receptor activation JS Nanda, WN Awadallah, SE Kohrt, P Popovics, JM Cates, J Mirosevich, ... BioRxiv: Jun 27, 2019 | 2 | 2019 |
| Cdc23/Mcm10 Primase Generates the Lagging Strand-Specific Ribonucleotide Imprint in Fission Yeast B Singh, KK Bisht, U Upadhyay, AC Kushwaha, JS Nanda, S Srivastava, ... bioRxiv, 303180, 2018 | 1 | 2018 |
| MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer B German, JN Singh, MAS Fonseca, DL Burkhart, A Sheahan, H Bergom, ... bioRxiv, 2024 | | 2024 |
| MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer LE Beatriz German, Jagpreet Singh Nanda, Marcos Ads Fonseca, Deborah L ... biorxiv, 2024 | | 2024 |
| Loss of tristetraprolin activates NF-κB induced phenotypic plasticity and primes transition to lethal prostate cancer KL Morel, AA Hamid, BG Falcón, JS Nanda, S Linder, AM Bergman, ... bioRxiv, 2022.08. 05.500896, 2022 | | 2022 |
| IL1B loss is associated with increased AR activity in castration-resistant prostate cancer WN Awadallah, JS Nanda, SE Kohrt, MM Grabowska bioRxiv, 2021.08. 31.458406, 2021 | | 2021 |
